Articles on disposables: implementation, validation, cost-benefit analysis - BioPharm International

ADVERTISEMENT

Disposables
The advantages and disadvantages of disposables, along with cost-benefit analyses, validation strategies, and implementation approaches.

Disposable Systems as a Platform Technology for R&D and Clinical Supply

August 1, 2010

How a Big Pharma company tackled the move to disposable bioreactors.

Bioterminology

February 2, 2010

A Guide to the Biopharmaceutical Lexicon, 2010 edition

Podcast Series

February 2, 2010

UPLC, QTof, HDMS, and more: A practical guide to the hottest techniques driving the future of biopharmaceutical science.

Resources

February 2, 2010

If you are looking for additional information (or terms not included in our glossary), here are some places to begin your search.

End-to-End Deployment of Single-Use Technology in Aseptic Filling of Vaccines at GSK

February 1, 2010

How this Big Pharma company successfully implemented disposable technologies in its manufacturing plant.

Freeze-Thaw Performance and Robustness Assessment of Celsius FFT 6L

December 1, 2009

A case study assesses freezing time and physical robustness under stress.

Disposables in Rapid Response Manufacturing: The Next Steps

December 1, 2009

Suppliers, manufacturers, and governments must work together to plan how best to develop and deploy disposable systems for emergency response.

Scale-Up and Comparison Studies Evaluating Disposable Bioreactors and Probes

November 2, 2009

Process performance was comparable across all scales, and fiber optic sensors appeared interchangeable with conventional probes.

Integrating Single-Use Connection Components into Filter Integrity Testing Reduces Manufacturing Risk

November 2, 2009

Single-use connections can help drug manufacturers maximize efficiency in every step of the manufacturing process.

ADVERTISEMENT

ADVERTISEMENT

Click here